Driving Drug Price Transparency for Doctors and Patients with Cam Deemer DrFirst

Published: Nov. 9, 2020, 6:39 p.m.

Cam Deemer, President, DrFirst shines light on the world of drug pricing and the lack of cost transparency for both doctors and patients. DrFirst is working with Prime Therapeutics, a PBM primarily focused on BlueCross and BlueShield, to integrate their data and provide drug price transparency to now 90% of covered lives. Cost is the number one reason people do not fill a prescription and patients are more likely to abandon an expensive prescription. Doctors and patients need to have an informed conversation about costs of therapy versus benefits of a particular drug.

@DrFirst\xa0 #pricetransparency #medadherence #medicaladherence

DrFirst.com

Download the transcript here